FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076191268> ?p ?o ?g. }

• W2076191268 endingPage "37" @default.
• W2076191268 startingPage "25" @default.
• W2076191268 abstract "Chronic myelocytic leukemia (CML) is a model system for the study of many aspects of malignant disease. One aspect that correlates with decreasing therapeutic response is tumor progression. This progression is often accompanied by clonal evolution. In those cases where aggressive therapy does not prevent this evolution, the clinical response to therapy usually proves to be poor and of short duration. Investigators are concentrating their efforts in three primary, but not mutually exclusive, areas with respect to the clinical management of CML. These include: an attempt to distinguish patients at risk for early transformation from those who will have a prolonged chronic phase; the cryopreservation of autologous bone marrow or buffy coat early in chronic phase for subsequent use in the accelerated phase and; endeavors to identify early markers for disease progression allowing intervention before an irreversible blast crisis occurs. This report deals with two types of potential prognostic markers of transformation: chromosomal and cell surface characteristics. The appearance of nonrandom abnormal chromosomal patterns has been correlated with myeloblastic transformation by many investigators. However, there has always been a subset of CML patients who do not undergo clonal evolution. Additionally, the type(s) of transformation in CML may vary depending on the cell lineages involved. Unlike myeloblastic transformants, many of our patients who do not exhibit clonal evolution as a concomitance of disease progression develop a lymphoblastic transformation. Cytofluorometric analysis can distinguish small populations of abnormal cells with lymphoblastic characteristics (HLA DR+). Initial data suggests that patients expressing the HLA DR+ in their normal peripheral blood cells are at risk of undergoing lymphoblastic transformation. The combined use of clinical, cytogenetic, and cytofluorometric data to predict an impending transformation and to discriminate between myeloblastic and lymphoblastic populations allows clinicians to manage their patients more effectively." @default.
• W2076191268 created "2016-06-24" @default.
• W2076191268 creator A5029968768 @default.
• W2076191268 creator A5054629368 @default.
• W2076191268 creator A5081435421 @default.
• W2076191268 creator A5082996532 @default.
• W2076191268 date "1987-05-01" @default.
• W2076191268 modified "2023-10-18" @default.
• W2076191268 title "Cytogenetics and cell surface marker analysis in chronic myelocytic leukemia. II. Implications for patient management" @default.
• W2076191268 cites W1041552879 @default.
• W2076191268 cites W1481581854 @default.
• W2076191268 cites W1510546584 @default.
• W2076191268 cites W1518456292 @default.
• W2076191268 cites W1555152937 @default.
• W2076191268 cites W1799579309 @default.
• W2076191268 cites W1855564826 @default.
• W2076191268 cites W1984558858 @default.
• W2076191268 cites W1992951254 @default.
• W2076191268 cites W1993725147 @default.
• W2076191268 cites W1998593414 @default.
• W2076191268 cites W199915037 @default.
• W2076191268 cites W2003881051 @default.
• W2076191268 cites W2014655715 @default.
• W2076191268 cites W2018650309 @default.
• W2076191268 cites W2034856462 @default.
• W2076191268 cites W2036348899 @default.
• W2076191268 cites W2041384730 @default.
• W2076191268 cites W2041695673 @default.
• W2076191268 cites W2043554825 @default.
• W2076191268 cites W2043955588 @default.
• W2076191268 cites W2046211176 @default.
• W2076191268 cites W2047197470 @default.
• W2076191268 cites W2048862562 @default.
• W2076191268 cites W2052282340 @default.
• W2076191268 cites W2052779132 @default.
• W2076191268 cites W2053818498 @default.
• W2076191268 cites W2060545245 @default.
• W2076191268 cites W2063334249 @default.
• W2076191268 cites W2066297886 @default.
• W2076191268 cites W2066337041 @default.
• W2076191268 cites W2069953765 @default.
• W2076191268 cites W2069988313 @default.
• W2076191268 cites W2079079115 @default.
• W2076191268 cites W2079932274 @default.
• W2076191268 cites W2083186776 @default.
• W2076191268 cites W2086644876 @default.
• W2076191268 cites W2111486924 @default.
• W2076191268 cites W2144016178 @default.
• W2076191268 cites W2164088012 @default.
• W2076191268 cites W2238668673 @default.
• W2076191268 cites W2313790933 @default.
• W2076191268 cites W2317083463 @default.
• W2076191268 cites W2322544432 @default.
• W2076191268 cites W2329676800 @default.
• W2076191268 cites W2394774512 @default.
• W2076191268 cites W2396079853 @default.
• W2076191268 cites W2399225123 @default.
• W2076191268 cites W2410403833 @default.
• W2076191268 cites W2418643011 @default.
• W2076191268 cites W2431503759 @default.
• W2076191268 cites W2436438954 @default.
• W2076191268 cites W2442153045 @default.
• W2076191268 cites W2470270793 @default.
• W2076191268 cites W293008173 @default.
• W2076191268 cites W343732061 @default.
• W2076191268 cites W38222106 @default.
• W2076191268 doi "https://doi.org/10.1016/0165-4608(87)90130-0" @default.
• W2076191268 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3470134" @default.
• W2076191268 hasPublicationYear "1987" @default.
• W2076191268 type Work @default.
• W2076191268 sameAs 2076191268 @default.
• W2076191268 citedByCount "4" @default.
• W2076191268 crossrefType "journal-article" @default.
• W2076191268 hasAuthorship W2076191268A5029968768 @default.
• W2076191268 hasAuthorship W2076191268A5054629368 @default.
• W2076191268 hasAuthorship W2076191268A5081435421 @default.
• W2076191268 hasAuthorship W2076191268A5082996532 @default.
• W2076191268 hasConcept C104317684 @default.
• W2076191268 hasConcept C113968399 @default.
• W2076191268 hasConcept C121608353 @default.
• W2076191268 hasConcept C142724271 @default.
• W2076191268 hasConcept C174475383 @default.
• W2076191268 hasConcept C203014093 @default.
• W2076191268 hasConcept C2776954793 @default.
• W2076191268 hasConcept C2779134260 @default.
• W2076191268 hasConcept C2779256057 @default.
• W2076191268 hasConcept C30481170 @default.
• W2076191268 hasConcept C54355233 @default.
• W2076191268 hasConcept C71924100 @default.
• W2076191268 hasConcept C86803240 @default.
• W2076191268 hasConceptScore W2076191268C104317684 @default.
• W2076191268 hasConceptScore W2076191268C113968399 @default.
• W2076191268 hasConceptScore W2076191268C121608353 @default.
• W2076191268 hasConceptScore W2076191268C142724271 @default.
• W2076191268 hasConceptScore W2076191268C174475383 @default.
• W2076191268 hasConceptScore W2076191268C203014093 @default.
• W2076191268 hasConceptScore W2076191268C2776954793 @default.
• W2076191268 hasConceptScore W2076191268C2779134260 @default.

• next